Inpatient Versus Outpatient Administration of CAR T-cell Therapy in relapsed/refractory (R/R) Diffuse Large B-cell Lymphoma (DLBCL): Real-World 30- and 60-Day Costs and Resource Utilization

Transplantation and Cellular Therapy 2026

View at publisher

Authors: Paola Ghione, Genevieve Meier, Madhu Palivela, Surbhi Shah, Samuel Hong, Sean P. Garrison, Benjamin J. Chastek

DOI: 10.1016/j.jtct.2025.12.254

Cited by: 0

Fields of Study & Subjects

CAR-T cell therapy research Economic and Financial Impacts of Cancer Health Systems Economic Evaluations Quality of Life